Product Details for NDA 011120
THORAZINE (CHLORPROMAZINE HYDROCHLORIDE)
30MG
Marketing Status: Discontinued
75MG
Marketing Status: Discontinued
150MG
Marketing Status: Discontinued
200MG
Marketing Status: Discontinued
300MG
Marketing Status: Discontinued
30MG
Marketing Status: Discontinued
Active Ingredient: CHLORPROMAZINE HYDROCHLORIDE
Proprietary Name: THORAZINE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N011120
Product Number: 016
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status: Discontinued
Patent and Exclusivity Information
THORAZINE (CHLORPROMAZINE HYDROCHLORIDE)
Proprietary Name: THORAZINE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N011120
Product Number: 016
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status: Discontinued
Patent and Exclusivity Information
75MG
Marketing Status: Discontinued
Active Ingredient: CHLORPROMAZINE HYDROCHLORIDE
Proprietary Name: THORAZINE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 75MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N011120
Product Number: 017
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status: Discontinued
Patent and Exclusivity Information
THORAZINE (CHLORPROMAZINE HYDROCHLORIDE)
Proprietary Name: THORAZINE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 75MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N011120
Product Number: 017
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status: Discontinued
Patent and Exclusivity Information
150MG
Marketing Status: Discontinued
Active Ingredient: CHLORPROMAZINE HYDROCHLORIDE
Proprietary Name: THORAZINE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 150MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N011120
Product Number: 018
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status: Discontinued
Patent and Exclusivity Information
THORAZINE (CHLORPROMAZINE HYDROCHLORIDE)
Proprietary Name: THORAZINE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 150MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N011120
Product Number: 018
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status: Discontinued
Patent and Exclusivity Information
200MG
Marketing Status: Discontinued
Active Ingredient: CHLORPROMAZINE HYDROCHLORIDE
Proprietary Name: THORAZINE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N011120
Product Number: 019
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status: Discontinued
Patent and Exclusivity Information
THORAZINE (CHLORPROMAZINE HYDROCHLORIDE)
Proprietary Name: THORAZINE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N011120
Product Number: 019
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status: Discontinued
Patent and Exclusivity Information
300MG
Marketing Status: Discontinued
Active Ingredient: CHLORPROMAZINE HYDROCHLORIDE
Proprietary Name: THORAZINE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 300MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N011120
Product Number: 020
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: THORAZINE
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 300MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N011120
Product Number: 020
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status: Discontinued
Patent and Exclusivity Information